anthrax
Microbial Immunity and VaccinesProgress towards the Development of a NEAT Vaccine for Anthrax II: Immunogen Specificity and Alum Effectiveness in an Inhalational ModelBacillus anthracis is the causative agent of anthrax disease, presents with high mortality, and has been at the center of bioweapon efforts. The only currently U.S. FDA-approved vaccine to prevent anthrax in humans is anthrax vaccine adsorbed (AVA), which is protective in several animal models and induces neutralizing antibodies against protective antigen (PA), the...
- Molecular Pathogenesis | SpotlightConstitutive MEK1 Activation Rescues Anthrax Lethal Toxin-Induced Vascular Effects In Vivo
- Microbial Immunity and VaccinesNeutralizing Monoclonal Antibody to Edema Toxin and Its Effect on Murine Anthrax
- Microbial Immunity and VaccinesInvestigation of New Dominant-Negative Inhibitors of Anthrax Protective Antigen Mutants for Use in Therapy and Vaccination
- Cellular Microbiology: Pathogen-Host Cell Molecular InteractionsCA-074Me Protection against Anthrax Lethal Toxin
- Microbial Immunity and VaccinesNod1/Nod2-Mediated Recognition Plays a Critical Role in Induction of Adaptive Immunity to Anthrax after Aerosol Exposure